From 27 to 30 January 2025, F2D Medical participated in the World Health Expo (WHX) Dubai, formerly known as Arab Health, held at the Dubai World Trade Centre. This major event brought together more than 3,800 exhibitors and over 60,000 visitors from 180 countries, providing a unique platform for innovation, collaboration and education in the field of healthcare.

At stand Z2D10, in partnership with its exclusive distributor DATAVITALIS, F2D Medical presented Thermodiag, a non-invasive medical device for continuous core body temperature monitoring. This innovative armband, the result of five years of research and development and three clinical studies, enables accurate measurement of core body temperature with a precision of 0.2°C, without causing discomfort to the patient.

Thermodiag has attracted considerable interest among healthcare professionals in the Middle East, particularly for its applications in oncology, post-operative care, home hospitalisation and intensive care units. Its ability to detect temperature changes early makes it particularly useful in the management of sepsis, a condition responsible for 20% of global deaths.

F2D Medical’s participation in WHX Dubai 2025 underscores its commitment to remaining at the forefront of healthcare innovation and collaborating with key industry players to improve patient care internationally.